The present invention pertains generally to the field of therapeutic compounds and more specifically to certain pyruvamide compounds of the formula, which, inter alia, inhibit a dust mite Group 1 peptidase allergen. and where the grating is relatively stable and has very low loss from scatter. The subject compositions are particularly useful in the treatment of obesity and type II diabetes, and associated diseases. The first set of code is executable by the plurality of processing units. Accordingly, the latency when establishing a connection can be reduced.